Swiss Federal Institute of Technology (ETH) Zürich , HCI H405, Wolfgang-Pauli-Strasse 10, CH-8093 Zürich, Switzerland.
Org Lett. 2012 Jul 20;14(14):3752-5. doi: 10.1021/ol301612q. Epub 2012 Jun 28.
A modular stereoselective synthesis of the vesicular monoamine transport inhibitors (+)-tetrabenazine ((+)-1) and (+)-α-dihydrotetrabenazine ((+)-2) has been developed. The approach is based on amine 4 and acid 5 as the key building blocks, which were elaborated into macrolactam 3 by amide coupling and a subsequent highly E-selective RCM reaction. Macrolactam 3 could be converted into tetrabenazine in three known steps.
已经开发出了一种囊泡单胺转运抑制剂(+)-四苯嗪((+)-1)和(+)-α-二氢四苯嗪((+)-2)的模块化立体选择性合成方法。该方法基于胺 4 和酸 5 作为关键构建块,通过酰胺偶联和随后的高 E-选择性 RCM 反应将其衍生为大环内酰胺 3。大环内酰胺 3 可以通过三个已知步骤转化为四苯嗪。